The Globe and Mail reports in its Wednesday, Feb. 7, edition that Stifel analyst Suthan Sukumar has reaffirmed his "buy" recommendation for Coveo Solutions. The Globe's David Leeder writes that Mr. Sukumar boosted his share target by a loonie to $15. Analysts on average target the shares at $13.50. Mr. Sukumar says in a note: "Coveo Solutions delivered a beat-and-raise print for FQ3. Revenues were modestly ahead and reflected early-signs of a broader demand recovery amidst a still challenging macro backdrop, while a stronger outperformance in operating losses underscores improving operating leverage with the company reaffirming positive cash-flows next year (while break-even year-to-date). Importantly, Coveo's new GenAI offering (launched in mid-Dec) accounted for 20 per cent of total bookings with an acceleration in signings. Notably, this momentum to-date remains driven by existing customers, but with adoption now increasingly across all solutions areas we believe this bodes well for net-new customer traction with potential for larger-scale deals as Coveo executes on their go-to-market plan. We raise our target price given strong execution with growing proof points on the GenAI scale opportunity."